An innovative security screening system from ThruVision, that can detect hidden explosives, liquids, narcotics, weapons, plastics and ceramics from a distance, has received the grand security product award in the ‘Best of what’s new 2008’ by the US Magazine ‘Popular Science’.
Called the T5000, the system forms images of metallic and non-metallic threat or contraband objects concealed under clothing out to distances of 25m. It was developed by UK security equipment manufacturer ThruVision Ltd, a spin out company of the Science and Technology Facilities Council.
Like all ThruVision products, the T5000 was developed to address personal privacy concerns now being raised in connection with the use of security imaging technologies. The T5000 avoids many of the acceptability issues associated with the use of imaging technologies in the public domain by non-intrusively detecting a wide range of contraband objects such as weapons, explosives, liquids and narcotics on walking or stationary people at various distances. Importantly the T5000 does this without revealing anatomical detail, thereby preserving the privacy of the subject. Concealed objects are shown against a silhouette of the human form.
The T5000 is also safe; it forms images of concealed objects by receiving natural low energy waves produced by people and their surroundings. Unlike an X-ray camera, the T5000 does not emit dangerous ionizing radiation so there is no threat to the operators or people being screened.
Clive Beattie, ThruVision CEO, said “We are very pleased and honoured to have received this award from Popular Science. The recent European Parliamentary decision to further study the health and human rights implications of full body scanners before their deployment in EU airports highlights the importance of all our products’ safety and privacy-related attributes. The ability to non-invasively screen for concealed objects at a distance offers a significant advantage to security system operators for applications including border and access control, counter-terrorism and asset protection.”
ThruVision’s passive imaging technology originally stems from research carried out at the Science and Technology Facilities Council’s Rutherford Appleton Laboratory to study dying stars. Dr Liz Towns Andrews, Director of Knowledge Exchange at STFC said: “This award is well-deserved recognition for ThruVision. STFC is totally committed to using its research facilities and scientific expertise to support and develop such innovative enterprises, so I’d like to congratulate ThruVision on this achievement.”
Wendy Taylor MCIPR | alfa
Success at leading conference on silicon materials science and technology in Japan
13.12.2018 | IHP - Leibniz-Institut für innovative Mikroelektronik
13.11.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
19.12.2018 | Materials Sciences
19.12.2018 | Materials Sciences
19.12.2018 | Life Sciences